Eric Harwood
8Patents
5h-index
25Co-inventors
55Inventor score
Filing activity: Nov 12, 2003 → Apr 27, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7825132B2 | Inhibition of FGFR3 and treatment of multiple myeloma | Human Necessities | 14 | Active |
| US8084615B2 | Antibacterial agents | Chemistry; Metallurgy | 9 | Active |
| US7989660B2 | Antibacterial agents | Chemistry; Metallurgy | 8 | Active |
| US8101640B2 | Antibacterial agents | Chemistry; Metallurgy | 8 | Active |
| US8614216B2 | Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salts | Human Necessities | 6 | Active |
| US8153843B2 | Antibacterial agents | Chemistry; Metallurgy | 4 | Active |
| US7838527B2 | Methods of treating cancer and related methods | Chemistry; Metallurgy | 2 | Active |
| US8222413B2 | Methods for synthesizing heterocyclic compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.